Perceptive Informatics Upgrades TrialWorks CTMS, DataLabs EDC



TOOLS

By Deborah Borfitz

Nov. 24, 2008Perceptive Informatics has just made some notable time-saving improvements to its specialized clinical trial management system (CTMS), all of which were developed based on feedback from the software’s current roster of over 40 company users. Version 2.1 of TrialWorks has updated functionality specific to reporting, data transfer, and analysis of study information, says President Steve Kent.

TrialWorks’ “My Reports” feature augments more than 175 standard, department-specific reports with an ad hoc reporting tool, allowing project teams to save and share reports of their own creation, says Kent. The upgrade also aligns the system with new reporting requirements of ClinicalTrials.gov, a registry of federally and privately supported clinical trials conducted worldwide. Furthermore, the system now offers greater flexibility to segment studies and information for analysis of clinical trial data.

Steve Kent, Perceptive Informatics, TrialWorks CTMS, DataLabs EDC
Steve Kent
The system overall is “highly intuitive…leading novice users to the right places” to accomplish their desired task, says Kent. Set-up can be accomplished in a couple of hours. Occasional users require only a few minutes of training. Unlike large companies that favor customized solutions, smaller firms “want to have a system that is easily hosted or installed, which covers all the bases,” including completing the right documentation and accurately tracking trial expenses.

As a matter of economy, TrialWorks has Microsoft’s primary database platform, SQL Server, on its backend rather than rival Oracle, says Kent. Smaller companies don’t want and can’t afford to have information technology teams devoted to both brands of software.

In terms of both customers and revenue, TrialWorks (previously part of the ClinPhone product portfolio) has been growing at a 25 percent annual clip, says Kent. It has been used for thousands of clinical trials.

Ultimately, TrialWorks will be fully integrated into a single-access, common interface of the eClinical platform provided by Perceptive Informatics. For now, a new web interface is available with TrialWorks 2.1 to simplify “one-off uploads” of patient and visit data and case report form (CRF) status from other systems, says Kent. This was previously a manual exercise.

Perceptive Informatics recently enhanced its DataLabs Electronic Data Capture and Clinical Data Management System solution (also a previous ClinPhone product) so that it better integrates with other Perceptive systems, including ClinPhone Interactive Voice and Web Response Systems, IMPACT (its leading enterprise CTMS solution), and its Medical Imaging solution.

DataLabs version 4.3 has an archive export feature for easier management and storage of selected study information, says Kent, which is designed to speed data lockdown on large trials. Workflow also gains momentum from the system’s enhanced ability to streamline data verification. The DataLabs solution now has read-only fields to prohibit modification of data from other systems while allowing users to perform queries and calculations based on that data. Additionally, data clarification forms can be customized and branded by study managers.

________________________________

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .